Beyond market trends, investors keen on maximizing returns delve into the world of stock picking. The right selections can be instrumental in catapulting your wealth.
Atyr Pharma Inc (NASDAQ: ATYR) closed the day trading at $3.13 down -3.99% from the previous closing price of $3.26. In other words, the price has decreased by -$3.99 from its previous closing price. On the day, 1.13 million shares were traded. ATYR stock price reached its highest trading level at $3.26 during the session, while it also had its lowest trading level at $3.07.
Ratios:
For a better understanding of ATYR, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 5.48 and its Current Ratio is at 5.48. In the meantime, Its Debt-to-Equity ratio is 0.19 whereas as Long-Term Debt/Eq ratio is at 0.17.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Leerink Partners on February 18, 2025, initiated with a Outperform rating and assigned the stock a target price of $16.
On October 04, 2024, Wells Fargo started tracking the stock assigning a Overweight rating and target price of $17.Wells Fargo initiated its Overweight rating on October 04, 2024, with a $17 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Mar 17 ’25 when Gross Jane A bought 3,750 shares for $4.00 per share. The transaction valued at 15,000 led to the insider holds 9,750 shares of the business.
Broadfoot Jill Marie sold 1,254 shares of ATYR for $4,740 on Feb 04 ’25. The Chief Financial Officer now owns 31,763 shares after completing the transaction at $3.78 per share. On Feb 04 ’25, another insider, DENYES NANCY, who serves as the General Counsel of the company, sold 899 shares for $3.78 each. As a result, the insider received 3,398 and left with 26,555 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ATYR now has a Market Capitalization of 278127424 and an Enterprise Value of 219098448. For the stock, the TTM Price-to-Sale (P/S) ratio is 1209.26 while its Price-to-Book (P/B) ratio in mrq is 3.76. Its current Enterprise Value per Revenue stands at 932.334 whereas that against EBITDA is -3.26.
Stock Price History:
The Beta on a monthly basis for ATYR is 0.92, which has changed by 0.6387434 over the last 52 weeks, in comparison to a change of 0.06429911 over the same period for the S&P500. Over the past 52 weeks, ATYR has reached a high of $4.66, while it has fallen to a 52-week low of $1.42. The 50-Day Moving Average of the stock is -14.33%, while the 200-Day Moving Average is calculated to be 14.30%.
Shares Statistics:
Over the past 3-months, ATYR traded about 1.29M shares per day on average, while over the past 10 days, ATYR traded about 1280950 shares per day. A total of 88.86M shares are outstanding, with a floating share count of 86.00M. Insiders hold about 3.22% of the company’s shares, while institutions hold 62.69% stake in the company. Shares short for ATYR as of 1741910400 were 6920509 with a Short Ratio of 5.35, compared to 1739491200 on 4354940. Therefore, it implies a Short% of Shares Outstanding of 6920509 and a Short% of Float of 9.51.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
